XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenues $ 3,894,447 $ 4,057,069
Cost of sales 1,940,025 2,078,437
Gross Profit 1,954,422 1,978,632
Operating expenses:    
General and administrative 2,682,658 3,579,522
Research and development 1,130,229 1,582,343
Sales and marketing 535,423 977,875
Total operating expenses 4,348,310 6,139,740
Loss from operations (2,393,888) (4,161,108)
Other income (expense):    
Interest expense, net (3,785,344) (305,497)
Loss on disposal of fixed assets (13,988)
Other income (expense), net (122,367) (132,894)
Total other expense, net (3,921,699) (438,391)
Net loss before provision for income taxes (6,315,587) (4,599,499)
Provision for income taxes
Net loss attributable to common stockholders $ (6,315,587) $ (4,599,499)
Net loss per common share - basic $ (0.77) $ (1.03)
Net loss per common share - diluted $ (0.77) $ (1.03)
Weighted average number of shares outstanding during the period - Basic 8,234,226 4,482,500
Weighted average number of shares outstanding during the period - Diluted 8,234,226 4,482,500
Comprehensive income (loss):    
Amortization of unrecognized periodic pension costs $ 43,345
Foreign currency cumulative translation adjustment (163,653) 51,259
Total comprehensive loss, net of tax (6,479,240) (4,504,895)
Accrued dividends on Series F Preferred Stock (61,235) (66,921)
Deemed dividends on Series F Preferred Stock (5,249,704) (255,976)
Total comprehensive loss available to common stockholders $ (11,790,179) $ (4,827,792)